Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling. Read more about Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling.
Myopathy associated BAG3 mutations lead to protein aggregation by stalling Hsp70 networks. Read more about Myopathy associated BAG3 mutations lead to protein aggregation by stalling Hsp70 networks.
The phospholipid PI(3,4)P2 is an apical identity determinant. Read more about The phospholipid PI(3,4)P2 is an apical identity determinant.
Integrative epigenetic taxonomy of primary prostate cancer. Read more about Integrative epigenetic taxonomy of primary prostate cancer.
Publisher Correction: Complex virome in feces from Amerindian children in isolated Amazonian villages. Read more about Publisher Correction: Complex virome in feces from Amerindian children in isolated Amazonian villages.
Recognition of host Clr-b by the inhibitory NKR-P1B receptor provides a basis for missing-self recognition. Read more about Recognition of host Clr-b by the inhibitory NKR-P1B receptor provides a basis for missing-self recognition.
Competing protein-protein interactions regulate binding of Hsp27 to its client protein tau. Read more about Competing protein-protein interactions regulate binding of Hsp27 to its client protein tau.
Publisher Correction: Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's disease. Read more about Publisher Correction: Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's disease.
HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons. Read more about HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons.
Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance. Read more about Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance.
